Limited Offer
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Stellate Cells in Health and Disease
- 1st Edition - April 8, 2015
- Editors: Chandrashekhar Gandhi, Massimo Pinzani
- Language: English
- Hardback ISBN:9 7 8 - 0 - 1 2 - 8 0 0 1 3 4 - 9
- eBook ISBN:9 7 8 - 0 - 1 2 - 8 0 0 5 4 4 - 6
Stellate Cells in Health and Disease is a comprehensive reference providing the most up-to-date knowledge and perspectives on the function of stellate cells affecting the liver and… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteStellate Cells in Health and Disease is a comprehensive reference providing the most up-to-date knowledge and perspectives on the function of stellate cells affecting the liver and other organs.
The text presents comprehensive coverage of their already established role in hepatic fibrosis along with the newer emerging evidence for stellate cell participation in the liver cell (hepatocyte) survival and regeneration, hepatic immunobiology, transplant tolerance, and liver cancer.
Chapters describe both animal and human research and the relevance of findings from animal research to human pathophysiology, and also contain sections on future directions which will be of special interest to basic and clinical researchers working on liver fibrosis, hepatic biology, and pathobiology.
- Presents coverage of the mechanisms of liver fibrosis with stellate cells as a target for therapy.
- Shows stellate cells as a major participant in hepatic immunobiology, including transplantation immunology.
- Key illustrations show the phenotypical changes in stellate cells in situ and tissue culture, their interactions with other cell types, signaling pathways and demonstrate the functions and roles of stellate cell in pathological processes.
Basic and clinical researchers of gastroenteology, as well as hepatologists and practicing gastroenterologists.
- Dedication
- List of Contributors
- Foreword
- What Have We Learned?
- The Outlook for Anti-Fibrotic Treatment
- References
- Preface
- Chapter 1. History and Early Work
- 1.1 Discovery of Hepatic Stellate Cells
- 1.2 HSCs and Vitamin A Homeostasis
- 1.3 Morphological Characteristics of HSCs
- 1.4 HSCs and Liver Fibrosis
- 1.5 Isolation and Culture of HSCs
- 1.6 Activation and Transdifferentiation of HSCs
- 1.7 Markers for HSCs
- 1.8 Perspective
- References
- Chapter 2. Hepatic Stellate Cell Culture Models
- 2.1 Isolation of Hepatic Stellate Cells
- 2.2 Single Cell Culture
- 2.3 In Vitro- Versus In Vivo-Activated HSCs
- 2.4 Single Cell Culture and 2D: Importance of Adhesion, Arg–Gly–Asp, and Matrix Components
- 2.5 HSC Co-Cultures with Kupffer Cells, Hepatocytes, LSEC, HCC, and CC Cells
- 2.6 In Vitro 3D Culture Systems
- 2.7 Conclusions
- References
- Chapter 3. Hepatic Fibrosis: A Global Clinical Problem
- 3.1 Introduction
- 3.2 Chronic Viral Hepatitis
- 3.3 NAFLD and NASH
- 3.4 Autoimmune Hepatitis, Primary Biliary Cirrhosis, and Primary Sclerosing Cholangitis
- 3.5 Etiology-Driven Liver Fibrosis
- References
- Chapter 4. Stellate Cells and Hepatic Fibrosis
- 4.1 Introduction
- 4.2 Pathogenesis of Hepatic Fibrosis
- 4.3 HSCs and Hepatic Fibrosis
- 4.4 New and Emerging Pathways of HSC Activation
- 4.5 Conclusions
- References
- Chapter 5. Cytokine Production and Signaling in Stellate Cells
- 5.1 Introduction
- 5.2 Platelet-Derived Growth Factor
- 5.3 Angiogenic Cytokines
- 5.4 TGF-β Superfamily
- 5.5 Chemokines
- 5.6 Tumor Necrosis Factor Superfamily
- 5.7 Interleukins and Interferons
- 5.8 Adipokines and Other Cytokines Related to Metabolism
- 5.9 Osteopontin
- 5.10 Perspective
- References
- Chapter 6. Stellate Cells, Portal Myofibroblasts, and Epithelial-to-Mesenchymal Transition
- 6.1 Introduction
- 6.2 Hepatic Stellate Cells
- 6.3 Portal Fibroblasts
- 6.4 Epithelial-to-Mesenchymal Transition
- 6.5 Perspective
- References
- Chapter 7. Matrix Metalloproteinases and Their Inhibitors
- 7.1 Introduction
- 7.2 The Metalloproteases (MMPs)
- 7.3 Relevance of MMP Activity and Matrix Degradation in Chronic Liver Disease
- 7.4 Conclusions
- References
- Chapter 8. Stellate Cells and Portal Hypertension
- Abbreviations
- 8.1 Overview
- 8.2 Cell Culture Based Studies
- 8.3 In Vivo Studies
- 8.4 Vasoactive Mediators and Stellate Cells
- 8.5 Therapeutic Implications
- Acknowledgment
- References
- Chapter 9. Hepatic Stellate Cells and Liver Cancer
- 9.1 Fibrosis and HCC
- 9.2 The Premalignant Microenvironment
- 9.3 The Tumor Microenvironment
- 9.4 HSCs as Potential Contributors to Cancer Promotion
- 9.5 Mechanisms by Which HSCs Promote HCC
- 9.6 Concluding Remarks
- References
- Chapter 10. Stellate Cells in Alcoholic Hepatitis
- 10.1 Introduction
- 10.2 Pathophysiology of Fibrosis in ALD
- 10.3 HSC and ASH
- 10.4 Direct Effects of Ethanol and its Metabolites on HSC
- 10.5 Interactions of HSCs with Innate Immune Systems in ASH
- 10.6 Interactions of HSCs with Adaptive Immunity in ASH
- 10.7 Summary: Potential Therapeutic Strategies for Reducing HSC Activation in ASH
- References
- Chapter 11. Hepatic Stellate Cells as Target for Reversal of Fibrosis/Cirrhosis
- 11.1 Introduction
- 11.2 Fibrosis Reversibility: General Overview
- 11.3 Mechanisms of HSC Clearance During Fibrosis Resolution
- 11.4 Control of HSC Fate and Matrix Degradation by Neighboring Liver Cells During Fibrosis Resolution
- 11.5 Conclusion
- Acknowledgments
- References
- Chapter 12. Interactions of Stellate Cells with Other Non-Parenchymal Cells
- 12.1 Hepatic Stellate Cells: Introductory Remarks
- 12.2 The Crosstalk of HSCs with Macrophages
- 12.3 HSC/MFs and Interactions with Other Cells of Innate and Adaptive Immunity
- 12.4 Interactions of HSCs and HSC/MFs with LSECs: From Liver Specific Pericytes to Pro-Angiogenic Cells
- 12.5 Interactions of HSCs and Portal Fibroblasts with Cholangiocytes
- 12.6 Concluding Remarks
- References
- Chapter 13. Hepatic Stellate Cells and Hepatocyte Survival
- 13.1 Introduction
- 13.2 HSC Phenotypes and Liver Injury
- 13.3 HSCs and Liver Regeneration
- 13.4 HSCs in Hepatocyte Injury During Endotoxemia
- 13.5 HSC Depletion Model to Study Acute Liver Injury
- 13.6 Perspective
- References
- Chapter 14. Stellate Cells in Hepatic Immunological Tolerance
- 14.1 Hepatic Immune System
- 14.2 Liver Tolerogenicity
- 14.3 Importance of HSCs in Transplantation
- 14.4 HSCs Produce Inflammatory and Immunoregulatory Cytokines and Chemokines
- 14.5 HSC–DC Interactions
- 14.6 HSCs and Conventional Effector T Cells
- 14.7 HSCs and Regulatory T Cells
- 14.8 HSCs and NKT Cells
- 14.9 Perspective
- Acknowledgment
- References
- Chapter 15. Stellate Cell Depletion Models
- 15.1 Introduction
- 15.2 Immune Cell Mediated Clearance of HM
- 15.3 HM Intrinsic Signaling Events that Limit Scar Cell Survival
- 15.4 Chemical Systems
- 15.5 Development of Carriers to Selectively Target Therapeutics to HMs
- 15.6 Advantages of HM Targeted Delivery Vehicles for Therapy
- 15.7 Nanoparticles and Viral Delivery Systems
- 15.8 Genetic Systems
- 15.9 The Role of HM Depletion in Liver Regeneration and Cancer
- 15.10 Future Perspectives
- References
- Chapter 16. Pancreatic Stellate Cells
- 16.1 Introduction
- 16.2 Pancreatic Stellate Cells—Isolation and Characterization
- 16.3 Role of PSCs in Pancreatic Disease
- 16.4 PSCs in Acute Pancreatitis
- 16.5 PSCs in Chronic Pancreatitis
- 16.6 Reversal of Pancreatic Fibrosis in Chronic Pancreatitis
- 16.7 PSCs in Pancreatic Cancer
- 16.8 Summary and Conclusions
- Acknowledgments
- References
- Index
- No. of pages: 336
- Language: English
- Edition: 1
- Published: April 8, 2015
- Imprint: Academic Press
- Hardback ISBN: 9780128001349
- eBook ISBN: 9780128005446
CG
Chandrashekhar Gandhi
Dr. Chandrashekhar Gandhi is a professor within the department of Surgery at the University of Cincinnati. His laboratory focuses on the mechanisms of intercellular communications that regulate the structure and function of the liver in physiology and pathology. Present research elucidates specific molecular and biochemical mechanisms underlying effects of stellate cells. Dr. Gandhi is a member of the American Association for Advancement of Science, The New York Academy of Sciences, American Society for Biochemistry and Molecular Biology, International Liver Transplantation Society, American Association for the Study of Liver Diseases, and the American Society for Investigative Pathology. He has contributed over 70 published research articles and owns the patent for “Diagnostic and Therapeutic Uses of Augmenter of Liver Regeneration (ALR) in Inflammatory Conditions” (PCT/US2008/075440).
Affiliations and expertise
Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, OH, USAMP
Massimo Pinzani
Affiliations and expertise
UCL Institute for Liver and Digestive Health, University College London, Royal Free Hospital Campus U3, UK